IL-22-Fc treatment restores liver insulin sensitivity, decreased hepatic triglyceride and cholesterol levels, and ameliorated liver steatosis in diet-induce obesity and db/db mice. The gene discussed is IL22; the disease is obesity due to melanocortin 4 receptor deficiency.